Sajad Mohammadi

Mr. Sajad Mohammadi

Pediatrics, Erasmus MC, Rotterdam, Zuid-Holland, The Netherlands
orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 May 2023 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
SMSajad Mohammadi
Sajad Mohammadi
FJFarzaneh Jabbari
Farzaneh Jabbari
VBValiollah Babaeipour
Valiollah Babaeipour

7 December 2023 in Pesticide Biochemistry and Physiology
Verified
Journal Article
Closed access
SMSajad Mohammadi
Sajad Mohammadi
FJFarzaneh Jabbari
Farzaneh Jabbari
GCGianluca Cidonio
Gianluca Cidonio
VBValiollah Babaeipour
Valiollah Babaeipour

17 October 2023 in Frontiers in Biomaterials Science
Verified
Journal Article
Open access
SMSajad Mohammadi
Sajad Mohammadi
GCGianluca Cidonio
Gianluca Cidonio
For decades, 3D bioprinting has offered a revolutionising approach to combine living cells and biomaterials to engineer complex, yet functional constructs. However, traditional 3D bioprinting platforms fall short of the ability to pattern complex gradients of biomaterials, cells, and ultimately bio-physical properties to drive tissue formation and regeneration. Recently, 3D microfluidic-assisted bioprinting (3DMB) has risen as a new hybrid approach for the fabrication of physiologically relevant tissues, adopting a microfluidic chip as functional printhead to achieve hierarchical patterning of bioinks and precise control over the microscale architecture of printed constructs, enabling the creation of multi-layered tissues. This review explores recent advancements in graded biomaterial patterning using microfluidic-assisted spinning and novel 3D bioprinting technologies. The physiological hierarchical arrangement of human tissues and the crucial role of biomaterials in achieving ordered assembly is hereby discussed. Lastly, the integration of microfluidic-assisted techniques with new bioprinting platforms is highlighted, examining the latest advancements in tissue regeneration and disease modelling.

31 December 2024 in Virtual and Physical Prototyping
Verified
Journal Article
Open access
SDSalvatore D’Alessandro
Salvatore D’Alessandro
SMSajad Mohammadi
Sajad Mohammadi
LILucia Iafrate
Lucia Iafrate
MBMarco Bastioli
Marco Bastioli
MMMartina Marcotulli
Martina Marcotulli
GCGianluca Cidonio
Gianluca Cidonio
3D bioprinting is at the forefront of tissue engineering to fabricate complex constructs resembling functional tissues. However, the inability to produce heterogeneous tissues and the lack of spatio-temporal control over the release of bioactive factors are greatly limiting clinical translation. Herein, the combination of 3D bioprinting with high-throughput dispensing using a custom microfluidic system and nanoclay-based inks is presented. This approach was found to enhance printability, retention, and controlled release of bioactive factors. Advanced tissue models were developed to resemble cancer and skeletal tissue, while studying the effect of anti-cancer (Doxorubicin) and pro-osteogenic growth factors (bone morphogenetic protein-2, BMP-2), respectively. The engineering of a new nanoclay ink allowed the sustained release, making it suitable for long-term applications. These findings suggest that by combining 3D bioprinting and high-throughput delivery of nanoclay-based inks a new platform for the engineering of functional tissue constructs can be assembled, offering significant advancements in regenerative medicine.

2 April 2024 in HardwareX
Verified
Journal Article
Open access
SMSajad Mohammadi
Sajad Mohammadi
SDSalvatore D’aLessandro
Salvatore D’aLessandro
FBFabiano Bini
Fabiano Bini
FMFranco Marinozzi
Franco Marinozzi
GCGianluca Cidonio
Gianluca Cidonio
The engineering of new 3D bioprinting approaches has shown great promise in the field of tissue engineering and disease modelling. However, the high cost of commercial 3D bioprinters has limited their accessibility, especially to those laboratories in resource-limited settings. Moreover, the need for a 3D bioprinting system capable of dispensing multiple materials is growing apace. Therefore, the development of a Microfluidic-assisted Open Source 3D bioprinting System (MOS3S) for the engineering of hierarchical tissues is needed to progress in fabricating functional tissues, but with a technology accessible to a wider range of researchers. The MOS3S platform is designed to allow the deposition of biomaterial inks using microfluidic printheads or coaxial nozzles for the in-situ crosslinking and scaffolds fabrication. The coupling of 3D printed syringe pumps with the motion control system is used for driving the tunable extrusion of inks for the fabrication of centimeter scale hierarchical lattice constructs for tissue engineering purposes. MOS3S performance have been validated to fabricate high-resolution structures with coaxial microfluidic technology, opening to new frontiers for seminal studies in pre-clinical disease modelling and tissue regeneration.

20 June 2024 in International Journal of Polymeric Materials and Polymeric Biomaterials
Verified
Journal Article
Closed access
FJFarzaneh Jabbari
Farzaneh Jabbari
SMSajad Mohammadi
Sajad Mohammadi
VBValiollah Babaeipour
Valiollah Babaeipour